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Epidemiology of Influenza Virus Types and 
Subtypes in South Africa, 2009–2012 
Technical Appendix 
Additional Modeling of Influenza A and B Virus, HIV Status, and Patient Age 
We found an association between age and influenza type and subtype in the multinomial 
model comparing influenza A(H3N2), A(H1N1)pdm09, and B. The association was significant 
in the comparison between A(H3N2) and A(H1N1)pdm09 but not when comparing A(H3N2) 
and B. This is probably due to the age shift of cases observed in South Africa and elsewhere 
during the first wave of A(H1N1)pdm09 circulation in 2009. In the logistic regression model to 
assess factors associated with influenza A (both A(H3N2) and A(H1N1)pdm09) and B, age did 
not have the same association. This is probably due to the fact that the age distribution of cases 
during the second wave (2011) of A(H1N1)pdm09 in South Africa was similar to those of 
A(H3N2) and B. When combining A(H3N2) and A(H1N1)pdm09 over the study period into the 
same category (all influenza A), the effect of the age shift during the first wave of 
A(H1N1)pdm09 circulation may be missed. On multivariate analysis, only year and HIV status 
remained statistically associated with influenza types and were retained in the final model 
(model presented in the text, which we will refer to as model 1). Age group was not significantly 
associated with influenza types nor had an interaction with HIV infection in the multivariate 
model, so we did not include age in the final model. Our final model (model 1) showed that, 
controlling for year, HIV infection was associated with influenza B compared to influenza A 
infection (adjusted odds ratio [aOR] 1.4, 95% CI 1.02–1.8). However, to explore this association 
further, since age may still have a confounding effect, we constructed additional models. In a 
model including year and age (model 2), age was not statistically significant (compared with <5 
year olds, 5–24 year olds aOR 1.4, 95% CI 0.9–2.3; 25–44 year olds aOR 1.3, 95% CI 0.95–1.8; 
45–64 year olds aOR 1.2, 0.8–1.8; and 65 year olds aOR 1.4, 0.8–2.7). In a model with year, 
age, and HIV infection (model 3), neither age (compared with <5 year olds, 5–24 year olds aOR 
1.5, 95% CI 0.9–2.7; 25–44 year olds aOR 1.2, 95% CI 0.8–1.9; 45–64 year olds aOR 1.1, 0.7–
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1.8; and 65 year olds aOR 1.5, 0.8–2.9) nor HIV infection (aOR 1.3, 95% CI 0.9–1.9) are 
statistically significant. However, the magnitude and direction of the adjusted odds ratio for HIV 
infection in model 3 are similar to those in model 1. We interpret this to mean that age is not 
correlated with influenza A versus B, and we are likely not powered to maintain the statistically 
significant association between HIV infection and influenza types when we also control for age. 
Of note, another study in South Africa using the same surveillance system found an association 
with influenza type and HIV when adjusting for age (1). 
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Technical Appendix Table. Characteristics of patients hospitalized with influenza-associated severe acute respiratory illness, by virus type and subtype—4 sites, South Africa, 2009–
2012* 
Characteristic 
Influenza type and subtype 
A(H3N2) (reference)  A(H1N1)pdm09  B 
No. pos/no. tested  
(% pos) 
No. pos/no. 
tested (% pos) 
Crude RRR 
(95% CI) 
Adjusted RRR 
(95% CI) 
No. pos/no. 
tested (% pos) 
Crude RRR 
(95% CI) 
Adjusted RRR 
(95% CI) 
Age group, y          
 <5 265/463 (57.2)  167/338 (49.4) Reference Reference  171/418 (40.9) Reference Reference 
 5–24 35/463 (7.6)  49/338 (14.5) 2.2 (1.4–3.6) 2.3 (1.4–3.8)  43/418 (10.3) 1.9 (1.2–3.1) 2.0 (1.2–3.4) 
 25–44 96/463 (20.7)  78/338 (23.1) 1.3 (0.9–1.8) 1.3 (0.9–2.0)  128/418 (30.6) 2.1 (1.5–2.9) 1.5 (1.0–2.1)† 
 45–64 44/463 (9.5)  35/338 (10.4) 1.3 (0.8–2.0) 1.4 (0.9–2.4)  55/418 (13.2) 1.9 (1.2–3.0) 1.4 (0.9–2.2) 
 65 23/463 (5.0)  9/338 (2.7) 0.6 (0.3–1.4) 0.6 (0.2–1.3)  21/418 (5.0) 1.4 (0.8–2.6) 1.1 (0.6–2.2) 
Male 207/461 (44.9)  149/336 (44.4) 1.0 (0.7–1.3)   177/417 (42.5) 0.9 (0.7–1.2)  
Black African 452/460 (98.3)  327/336 (97.3) 1.6 (0.6–4.1)   407/416 (97.8) 1.2 (0.5–3.3)  
Site           
 Soweto 337/463 (72.8)  235/338 (69.5) Reference   292/418 (69.9) Reference  
 Agincourt 77/463 (16.6)  70/338 (20.7) 1.3 (0.9–1.9)   55/418 (13.2) 0.8 (0.6–1.2)  
 Pietermaritzburg 28/463 (6.1)  20/338 (5.9) 1.0 (0.6–1.9)   43/418 (10.3) 1.8 (1.1–2.9)  
 Klerksdorp 21/463 (4.5)  13/338 (3.9) 0.9 (0.6–0.8)   28/418 (6.7) 1.5 (0.9–2.8)  
Year          
 2009 194/463 (41.9)  160/338 (47.3) Reference Reference  25/418 (6.0) Reference Reference 
 2010 72/463 (15.6)  37/338 (11.0) 0.6 (0.4–1.0)† 0.6 (0.4–1.0)†  164/418 (39.2) 17.7 (10.7–29.1) 16.8 (10.1–27.9) 
 2011 98/463 (21.2)  140/338 (41.4) 1.7 (1.2–2.4) 1.7 (1.2–2.5)  124/418 (29.7) 9.8 (6.0–16.1) 9.5 (5.7–15.6) 
 2012 99/463 (21.4)  1/338 (0.3) 0 (0–0.1) 0.0 (0.0–0.1)  105/418 (25.1) 8.2 (5.0–13.6) 7.8 (4.7–13.0) 
Co-infections and underlying medical 
conditions 
         
 HIV infection 112/311 (36.0)  110/271 (40.6) 1.2 (0.9–1.7)   170/352 (48.3) 1.7 (1.2–2.3)  
 Tuberculosis 42/458 (9.2)  34/335 (10.2) 1.1 (0.7–1.8)   38/411 (9.3) 1.0 (0.6–1.6)  
 Underlying medical conditions 
 excluding tuberculosis, HIV‡ 
34/460 (7.4)  31/336 (9.2) 1.3 (0.8–2.1)   38/417 (9.1) 1.3 (0.8–2.0)  
 Pregnancy  3/251 (1.2)  2/187 (1.1) 0.9 (0.1–5.4)   3/24 (1.3) 1.0 (0.2–5.2)  
 Pneumococcal co-infection  
 detected by PCR 
23/310 (7.4)  25/286 (8.7) 1.2 (0.7–2.2)   32/325 (9.9) 1.4 (0.8–2.2)  
 Respiratory syncytial virus infection 32/463 (6.9)  14/331 (4.2) 0.6 (0.3–1.1)   22/418 (5.3) 0.7 (0.4–1.3)  
 Adenovirus infection 99/463 (21.4)  24/331 (7.3) 0.3 (0.2–0.5)   69/418 (16.5) 0.7 (0.5–1.0)§  
 Parainfluenzavirus 1, 2, or 3 infection 14/463 (3.0)  13/338 (3.9) 1.3 (0.6–2.8)   17/418 (4.1) 1.4 (0.7–2.8)  
 Human metapneumovirus infection 6/463 (1.3)  8/331 (2.4) 1.9 (0.6–5.5)   4/418 (1.0) 0.7 (0.2–2.6)  
 Rhinovirus infection 61/462 (13.2)  30/331 (9.1) 0.7 (0.4–1.0)§   57/418 (13.6) 1.0 (0.7–1.5)  
 Enterovirus infection 16/463 (3.5)  5/331 (1.5) 0.4 (0.2–1.2)   12/418 (2.9) 0.8 (0.4–1.8)  
Clinical presentation and course          
 Temperature >38°C 181/364 (49.7)  141/287 (49.1) 1.0 (0.7–1.3)   138/407 (33.9) 0.5 (0.4–0.7)  
 Cough ¶ 255/264 (96.6)  162/167 (97.0) 1.1 (0.4–3.5)   163/170 (95.9) 0.8 (0.3–2.2)  
 Tachypnea¶ 99/250 (39.6)  73/161 (45.3) 1.3 (0.8–1.9)   62/159 (39.0) 1.0 (0.6–1.5)  
 Difficulty breathing¶ 188/264 (71.2)  125/167 (74.9) 1.2 (0.8–1.9)   111/170 (65.3) 0.8 (0.5–1.1)  
 Chest wall indrawing¶ 96/264 (36.4)  77/167 (46.1) 1.5 (1.0–2.2)§   56/170 (32.9) 0.9 (0.6–1.3)  
 Stridor¶ 30/264 (11.4)  20/167 (12.0) 1.1 (0.6–1.9)   36/170 (21.2) 2.1 (1.2–3.6)  
 Tachycardia¶ 132/264 (50.0)  95/167 (56.9) 1.3 (0.9–1.9)   88/170 (51.8) 1.1 (0.7–1.6)  
 Diarrhea¶ 50/264 (18.9)  28/167 (16.8) 0.9 (0.5–1.4)   32/170 (18.8) 1.0 (0.6–1.6)  
 Unable to eat¶ 66/264 (25.0)  43/167 (25.8) 1.0 (0.7–1.6)   35/170 (20.6) 0.8 (0.5–1.2)  
 Vomiting¶ 70/264 (26.5)  52/167 (31.1) 1.3 (0.8–1.9)   53/170 (31.2) 1.3 (0.8–1.9)  
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Characteristic 
Influenza type and subtype 
A(H3N2) (reference)  A(H1N1)pdm09  B 
No. pos/no. tested  
(% pos) 
No. pos/no. 
tested (% pos) 
Crude RRR 
(95% CI) 
Adjusted RRR 
(95% CI) 
No. pos/no. 
tested (% pos) 
Crude RRR 
(95% CI) 
Adjusted RRR 
(95% CI) 
 Lethargy¶ 53/264 (20.1)  32/167 (19.2) 0.9 (0.6–1.5)   30/170 (17.7) 0.9 (0.5–1.4)  
 Symptoms 3 d before admission 206/452 (45.6)  153/335 (45.7) 1.0 (0.8–1.3)   239/415 (57.6) 1.6 (1.2–2.1)  
 Admission to intensive care unit 4/457 (0.9)  3/336 (0.9) 1.0 (0.2–4.6)   4/411 (1.0) 1.1 (0.3–4.5)  
 Mechanical ventilation needed 3/457 (0.7)  1/336 (0.3) 0.5 (0.0–4.4)   4/411 (1.0) 1.5 (0.3–6.7)  
 Supplemental oxygen needed  138/457 (30.2)  117/336 (34.8) 1.2 (0.9–1.7)   144/411 (35.0) 1.2 (0.9–1.7)  
 Antimicrobial drugs prescribed at  
 admission 
402/421 (95.7)  321/335 (95.8) 1.0 (0.5–2.1)   384/395 (97.2) 1.6 (0.7–3.4)  
 Duration of hospitalization >2 d 319/451 (70.7)  255/332 (76.8) 1.4 (1.0–1.9)§   323/407 (79.4) 1.6 (1.2–2.2)  
Case-fatality ratio, no. who died  13/459 (2.8)  5/334 (1.5) 0.5 (0.2–1.5)   16/412 (3.9) 1.4 (0.7–2.9)  
*Pos, positive; RRR, relative risk ratio. 
†p<0.05. 
‡Asthma, other chronic lung disease, chronic heart disease (valvular heart disease, coronary artery disease, or heart failure excluding hypertension), liver disease (cirrhosis or liver failure), renal disease 
(nephrotic syndrome, chronic renal failure), diabetes mellitus, immunocompromising conditions excluding HIV infection (organ transplant, immunosuppressive therapy, immunoglobulin deficiency, malignancy), 
neurologic disease (cerebrovascular accident, spinal cord injury, seizures, neuromuscular conditions), or pregnancy. Concurrent conditions were considered absent for patients for whom the medical records 
stated that the patient had no underlying medical condition or when there was no direct reference to that condition.  
§p>0.05. 
¶Patients <5 y of age. 
 
 
